{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T12:12:41Z","timestamp":1790770361710,"version":"4.1.0"},"reference-count":101,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2016,12,16]],"date-time":"2016-12-16T00:00:00Z","timestamp":1481846400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Netherlands Organization for Scientific Research"},{"name":"Netherlands Brain Foundation"},{"DOI":"10.13039\/501100001826","name":"ZonMw","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001826","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001262","name":"National Parkinson Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001262","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003246","name":"Nederlandse Organisatie voor Wetenschappelijk Onderzoek","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003246","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Internationaal Parkinson Fonds"},{"DOI":"10.13039\/501100008358","name":"Hersenstichting Nederland","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100008358","id-type":"DOI","asserted-by":"crossref"}]},{"name":"UCB"},{"DOI":"10.13039\/100006483","name":"Abbvie","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006483","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Michael J. Fox foundation"},{"DOI":"10.13039\/100015453","name":"Adamas","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100015453","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100007773","name":"Danone","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007773","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Zambon"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1007\/s00415-016-8357-z","type":"journal-article","created":{"date-parts":[[2016,12,17]],"date-time":"2016-12-17T06:20:36Z","timestamp":1481955636000},"page":"1559-1566","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":49,"title":["The clinical heterogeneity of drug-induced myoclonus: an illustrated review"],"prefix":"10.1007","volume":"264","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8470-3050","authenticated-orcid":false,"given":"Sabine","family":"Janssen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bastiaan R.","family":"Bloem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bart P.","family":"van de Warrenburg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,12,16]]},"reference":[{"key":"8357_CR1","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/0013-4694(94)00268-P","volume":"94","author":"U Aguglia","year":"1995","unstructured":"Aguglia U, Gambardella A, Zappia M, Valentino P, Quattrone A (1995) Negative myoclonus during valproate-related stupor. Neurophysiological evidence of a cortical non-epileptic origin. Electroencephalogr Clin Neurophysiol 94:103\u2013108","journal-title":"Electroencephalogr Clin Neurophysiol"},{"key":"8357_CR2","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1017\/S0265021507002578","volume":"25","author":"JA Alfa","year":"2008","unstructured":"Alfa JA, Bamgbade OA (2008) Acute myoclonus following spinal anaesthesia. Eur J Anaesthesiol 25:256\u2013257","journal-title":"Eur J Anaesthesiol"},{"key":"8357_CR3","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1097\/01.WNF.0000220825.65393.93","volume":"29","author":"H Alonso-Navarro","year":"2006","unstructured":"Alonso-Navarro H, Jimenez-Jimenez FJ (2006) Reversible tremor, myoclonus, and fasciculations associated with topiramate use for migraine. Clin Neuropharmacol 29:157\u2013159","journal-title":"Clin Neuropharmacol"},{"key":"8357_CR4","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1111\/j.1528-1157.2000.tb00192.x","volume":"41","author":"J Asconape","year":"2000","unstructured":"Asconape J, Diedrich A, DellaBadia J (2000) Myoclonus associated with the use of gabapentin. Epilepsia 41:479\u2013481","journal-title":"Epilepsia"},{"key":"8357_CR5","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/BF01244633","volume":"72","author":"JJ Askenasy","year":"1988","unstructured":"Askenasy JJ, Yahr MD (1988) Is monoamine oxidase inhibitor induced myoclonus serotoninergically mediated? J Neural Transm 72:67\u201376","journal-title":"J Neural Transm"},{"key":"8357_CR6","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1097\/00004714-199608000-00016","volume":"16","author":"Y Barak","year":"1996","unstructured":"Barak Y, Levine J, Weisz R (1996) Clozapine-induced myoclonus: two case reports. J Clin Psychopharmacol 16:339\u2013340","journal-title":"J Clin Psychopharmacol"},{"key":"8357_CR7","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.neucli.2006.12.003","volume":"36","author":"C Brefel-Courbon","year":"2006","unstructured":"Brefel-Courbon C, Gardette V, Ory F, Montastruc JL (2006) Drug-induced myoclonus: a French pharmacovigilance database study. Neurophysiol Clin 36:333\u2013336","journal-title":"Neurophysiol Clin"},{"key":"8357_CR8","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1097\/00004850-198710000-00006","volume":"2","author":"M Casas","year":"1987","unstructured":"Casas M, Garcia-Ribera C, Alvarez E, Udina C, Queralto JM, Grau JM (1987) Myoclonic movements as a side-effect of treatment with therapeutic doses of clomipramine. Int Clin Psychopharmacol 2:333\u2013336","journal-title":"Int Clin Psychopharmacol"},{"key":"8357_CR9","first-page":"965","volume":"6","author":"M Casazza","year":"1985","unstructured":"Casazza M, Bracchi M, Girotti F (1985) Spinal myoclonus and clinical worsening after intravenous contrast medium in a patient with spinal arteriovenous malformation. AJNR Am J Neuroradiol 6:965\u2013966","journal-title":"AJNR Am J Neuroradiol"},{"key":"8357_CR10","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/S1474-4422(04)00880-4","volume":"3","author":"JN Caviness","year":"2004","unstructured":"Caviness JN, Brown P (2004) Myoclonus: current concepts and recent advances. Lancet Neurol 3:598\u2013607","journal-title":"Lancet Neurol"},{"key":"8357_CR11","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1001\/archneur.60.3.401","volume":"60","author":"JN Caviness","year":"2003","unstructured":"Caviness JN, Evidente VG (2003) Cortical myoclonus during lithium exposure. Arch Neurol 60:401\u2013404","journal-title":"Arch Neurol"},{"issue":"6","key":"8357_CR12","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1007\/s00540-016-2228-8","volume":"30","author":"SH Chaw","year":"2016","unstructured":"Chaw SH, Chan L, Lee PK, Bakar JA, Rasiah R, Foo LL (2016) Prolonged drug-induced myoclonus: is it related to palonosetron? J Anesth 30(6):1063\u20131066","journal-title":"J Anesth"},{"key":"8357_CR13","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1212\/01.wnl.0000174517.21383.36","volume":"65","author":"A Crespel","year":"2005","unstructured":"Crespel A, Genton P, Berramdane M, Coubes P, Monicard C, Baldy-Moulinier M, Gelisse P (2005) Lamotrigine associated with exacerbation or de novo myoclonus in idiopathic generalized epilepsies. Neurology 65:762\u2013764","journal-title":"Neurology"},{"key":"8357_CR14","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1097\/00004714-198812000-00024","volume":"8","author":"DP Devanand","year":"1988","unstructured":"Devanand DP, Sackeim HA, Brown RP (1988) Myoclonus during combined tricyclic antidepressant and lithium treatment. J Clin Psychopharmacol 8:446\u2013447","journal-title":"J Clin Psychopharmacol"},{"key":"8357_CR15","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1056\/NEJM200401013500121","volume":"350","author":"EG Dib","year":"2004","unstructured":"Dib EG, Bernstein S, Benesch C (2004) Multifocal myoclonus induced by trimethoprim-sulfamethoxazole therapy in a patient with nocardia infection. N Engl J Med 350:88\u201389","journal-title":"N Engl J Med"},{"key":"8357_CR16","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/s10072-009-0104-0","volume":"30","author":"C Dominguez","year":"2009","unstructured":"Dominguez C, Benito-Leon J, Bermejo-Pareja F (2009) Multifocal myoclonus induced by haloperidol. Neurol Sci 30:385\u2013386","journal-title":"Neurol Sci"},{"key":"8357_CR17","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1097\/00002826-199619060-00009","volume":"19","author":"J Duarte","year":"1996","unstructured":"Duarte J, Sempere AP, Cabezas MC, Marcos J, Claveria LE (1996) Postural myoclonus induced by phenytoin. Clin Neuropharmacol 19:536\u2013538","journal-title":"Clin Neuropharmacol"},{"key":"8357_CR18","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1590\/S0004-282X2008000600025","volume":"66","author":"LA Dutra","year":"2008","unstructured":"Dutra LA, Pedroso JL, Felix EP, Barsottini OG (2008) Venlafaxine induced-myoclonus in a patient with mixed dementia. Arq Neuropsiquiatr 66:894\u2013895","journal-title":"Arq Neuropsiquiatr"},{"key":"8357_CR19","doi-asserted-by":"crossref","first-page":"e4","DOI":"10.1016\/j.jpainsymman.2010.08.005","volume":"40","author":"S Essandoh","year":"2010","unstructured":"Essandoh S, Sakae M, Miller J, Glare PA (2010) A cautionary tale from critical care: resolution of myoclonus after fentanyl rotation to hydromorphone. J Pain Symptom Manage 40:e4\u20136","journal-title":"J Pain Symptom Manage"},{"key":"8357_CR20","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1212\/WNL.52.1.211","volume":"52","author":"VG Evidente","year":"1999","unstructured":"Evidente VG, Caviness JN (1999) Focal cortical transient preceding myoclonus during lithium and tricyclic antidepressant therapy. Neurology 52:211\u2013213","journal-title":"Neurology"},{"key":"8357_CR21","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/0163-8343(94)00065-L","volume":"17","author":"J Farrington","year":"1995","unstructured":"Farrington J, Stoudemire A, Tierney J (1995) The role of ciprofloxacin in a patient with delirium due to multiple etiologies. Gen Hosp Psychiatry 17:47\u201353","journal-title":"Gen Hosp Psychiatry"},{"key":"8357_CR22","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1002\/mds.870080225","volume":"8","author":"A Ferbert","year":"1993","unstructured":"Ferbert A, Biniek R, Kindler J, Maurin N (1993) Myoclonus and tremor induced acutely by administration of tumor necrosis factor in a patient with Ehlers-Danlos syndrome. Mov Disord 8:232\u2013233","journal-title":"Mov Disord"},{"key":"8357_CR23","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1097\/JCP.0b013e318167465f","volume":"28","author":"P Fernandez Corcuera","year":"2008","unstructured":"Fernandez Corcuera P, Pomarol E, Amann B, McKenna P (2008) Myoclonus provoked by lamotrigine in a bipolar patient. J Clin Psychopharmacol 28:248\u2013249","journal-title":"J Clin Psychopharmacol"},{"key":"8357_CR24","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1176\/jnp.10.4.472a","volume":"10","author":"J Finsterer","year":"1998","unstructured":"Finsterer J, Lubec D, Verlicchi A, Samec P (1998) Facial myocloni and stroke as late sequelae of metrizamide myelography. J Neuropsychiatry Clin Neurosci 10:472\u2013473","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"8357_CR25","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1016\/0006-3223(90)90048-7","volume":"27","author":"H Fukuzako","year":"1990","unstructured":"Fukuzako H, Tominaga H, Izumi K, Koja T, Nomoto M, Hokazono Y, Kamei K, Fujii H, Fukuda T, Matsumoto K (1990) Postural myoclonus associated with long-term administration of neuroleptics in schizophrenic patients. Biol Psychiatry 27:1116\u20131126","journal-title":"Biol Psychiatry"},{"key":"8357_CR26","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1001\/archpsyc.1987.01800150081010","volume":"44","author":"MJ Garvey","year":"1987","unstructured":"Garvey MJ, Tollefson GD (1987) Occurrence of myoclonus in patients treated with cyclic antidepressants. Arch Gen Psychiatry 44:269\u2013272","journal-title":"Arch Gen Psychiatry"},{"key":"8357_CR27","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1111\/j.1528-1157.1998.tb01299.x","volume":"39","author":"P Genton","year":"1998","unstructured":"Genton P, Nguyen VH, Mesdjian E (1998) Carbamazepine intoxication with negative myoclonus after the addition of clobazam. Epilepsia 39:1115\u20131118","journal-title":"Epilepsia"},{"key":"8357_CR28","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/j.amjmed.2015.03.001","volume":"128","author":"JL Gentry 3rd","year":"2015","unstructured":"Gentry JL 3rd, Peterson C (2015) Death delusions and myoclonus: acyclovir toxicity. Am J Med 128:692\u2013694","journal-title":"Am J Med"},{"key":"8357_CR29","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1186\/1471-2431-13-187","volume":"13","author":"M George","year":"2013","unstructured":"George M, Haasz M, Coronado A, Salhanick S, Korbel L, Kitzmiller JP (2013) Acute dyskinesia, myoclonus, and akathisa in an adolescent male abusing quetiapine via nasal insufflation: a case study. BMC Pediatr 13:187","journal-title":"BMC Pediatr"},{"key":"8357_CR30","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1089\/104454601750284126","volume":"11","author":"N Ghaziuddin","year":"2001","unstructured":"Ghaziuddin N, Iqbal A, Khetarpal S (2001) Myoclonus during prolonged treatment with sertraline in an adolescent patient. J Child Adolesc Psychopharmacol 11:199\u2013202","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"8357_CR31","doi-asserted-by":"crossref","first-page":"2264","DOI":"10.1002\/mds.23140","volume":"25","author":"A Gupta","year":"2010","unstructured":"Gupta A, Lang AE (2010) Drug-induced cranial myoclonus. Mov Disord 25:2264\u20132265","journal-title":"Mov Disord"},{"key":"8357_CR32","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/S0885-3924(01)00370-0","volume":"23","author":"PK Han","year":"2002","unstructured":"Han PK, Arnold R, Bond G, Janson D, Abu-Elmagd K (2002) Myoclonus secondary to withdrawal from transdermal fentanyl: case report and literature review. J Pain Symptom Manage 23:66\u201372","journal-title":"J Pain Symptom Manage"},{"key":"8357_CR33","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1089\/cap.2009.0010","volume":"20","author":"G Horga","year":"2010","unstructured":"Horga G, Horga A, Baeza I, Castro-Fornieles J, Lazaro L, Pons A (2010) Drug-induced speech dysfluency and myoclonus preceding generalized tonic-clonic seizures in an adolescent male with schizophrenia. J Child Adolesc Psychopharmacol 20:233\u2013234","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"8357_CR34","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1136\/jnnp.74.4.547","volume":"74","author":"AC Hui","year":"2003","unstructured":"Hui AC, Wong TY, Chow KM, Szeto CC (2003) Multifocal myoclonus secondary to tranexamic acid. J Neurol Neurosurg Psychiatry 74:547","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"8357_CR35","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1046\/j.1528-1157.2001.44000.x","volume":"42","author":"HJ Huppertz","year":"2001","unstructured":"Huppertz HJ, Feuerstein TJ, Schulze-Bonhage A (2001) Myoclonus in epilepsy patients with anticonvulsive add-on therapy with pregabalin. Epilepsia 42:790\u2013792","journal-title":"Epilepsia"},{"key":"8357_CR36","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1212\/WNL.0000000000001393","volume":"84","author":"P Immovilli","year":"2015","unstructured":"Immovilli P, Rota E, Morelli N, Iafelice I, Magnacavallo A, Guidetti D (2015) Metoclopramide-induced facial and palatopharyngeal myoclonus. Neurology 84:1284","journal-title":"Neurology"},{"key":"8357_CR37","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1002\/mds.22076","volume":"23","author":"T Irioka","year":"2008","unstructured":"Irioka T, Machida A, Yokota T, Mizusawa H (2008) Antihistamine-associated myoclonus: a case report. Mov Disord 23:1615\u20131616","journal-title":"Mov Disord"},{"key":"8357_CR38","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1093\/ageing\/afq107","volume":"39","author":"S Jayathissa","year":"2010","unstructured":"Jayathissa S, Woolley M, Ganasegaram M, Holden J, Cu E (2010) Myoclonus and delirium associated with ciprofloxacin. Age Ageing 39:762","journal-title":"Age Ageing"},{"key":"8357_CR39","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1097\/00002826-200209000-00002","volume":"25","author":"A Jimenez-Huete","year":"2002","unstructured":"Jimenez-Huete A, Gil-Nagel A, Franch O (2002) Multifocal myoclonus associated with mefloquine chemoprophylaxis. Clin Neuropharmacol 25:243","journal-title":"Clin Neuropharmacol"},{"key":"8357_CR40","doi-asserted-by":"crossref","first-page":"93","DOI":"10.2165\/00023210-200418020-00003","volume":"18","author":"FJ Jimenez-Jimenez","year":"2004","unstructured":"Jimenez-Jimenez FJ, Puertas I, de Toledo-Heras M (2004) Drug-induced myoclonus: frequency, mechanisms and management. CNS Drugs 18:93\u2013104","journal-title":"CNS Drugs"},{"key":"8357_CR41","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1007\/s15010-004-3011-6","volume":"32","author":"F Jundt","year":"2004","unstructured":"Jundt F, Lempert T, Dorken B, Pezzutto A (2004) Trimethoprim-sulfamethoxazole exacerbates posthypoxic action myoclonus in a patient with suspicion of Pneumocystis jiroveci infection. Infection 32:176\u2013178","journal-title":"Infection"},{"key":"8357_CR42","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1097\/00004714-198308000-00034","volume":"3","author":"P Kettl","year":"1983","unstructured":"Kettl P, DePaulo JR Jr (1983) Maprotiline-induced myoclonus. J Clin Psychopharmacol 3:264\u2013265","journal-title":"J Clin Psychopharmacol"},{"key":"8357_CR43","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1007\/BF00428910","volume":"44","author":"HL Klawans","year":"1975","unstructured":"Klawans HL, D\u2019Amico DJ, Patel BC (1975) Behavioral supersensitivity to 5-hydroxytryptophan induced by chronic methysergide pretreatment. Psychopharmacologia 44:297\u2013300","journal-title":"Psychopharmacologia"},{"key":"8357_CR44","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1177\/1756285610395653","volume":"4","author":"M Kojovic","year":"2011","unstructured":"Kojovic M, Cordivari C, Bhatia K (2011) Myoclonic disorders: a practical approach for diagnosis and treatment. Ther Adv Neurol Disord 4:47\u201362","journal-title":"Ther Adv Neurol Disord"},{"key":"8357_CR45","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1111\/j.1528-1167.2007.01165_3.x","volume":"48","author":"E Kutluay","year":"2007","unstructured":"Kutluay E, Pakoz B, Beydoun A (2007) Reversible facial myoclonus with topiramate therapy for epilepsy. Epilepsia 48:2001\u20132002","journal-title":"Epilepsia"},{"key":"8357_CR46","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1213\/00000539-198501000-00017","volume":"64","author":"TP Laughlin","year":"1985","unstructured":"Laughlin TP, Newberg LA (1985) Prolonged myoclonus after etomidate anesthesia. Anesth Analg 64:80\u201382","journal-title":"Anesth Analg"},{"key":"8357_CR47","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1097\/00002826-199903000-00004","volume":"22","author":"EC Lauterbach","year":"1999","unstructured":"Lauterbach EC (1999) Hiccup and apparent myoclonus after hydrocodone: review of the opiate-related hiccup and myoclonus literature. Clin Neuropharmacol 22:87\u201392","journal-title":"Clin Neuropharmacol"},{"key":"8357_CR48","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1002\/mds.870090314","volume":"9","author":"EC Lauterbach","year":"1994","unstructured":"Lauterbach EC (1994) Reversible intermittent rhythmic myoclonus with fluoxetine in presumed Pick\u2019s disease. Mov Disord 9:343\u2013346","journal-title":"Mov Disord"},{"key":"8357_CR49","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1176\/ajp.134.1.90","volume":"134","author":"S Lippmann","year":"1977","unstructured":"Lippmann S, Moskovitz R, O\u2019Tuama L (1977) Tricyclic-induced myoclonus. Am J Psychiatry 134:90\u201391","journal-title":"Am J Psychiatry"},{"key":"8357_CR50","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1684\/epd.2012.0504","volume":"14","author":"A Magaudda","year":"2012","unstructured":"Magaudda A, Di Rosa G (2012) Carbamazepine-induced non-epileptic myoclonus and tic-like movements. Epileptic Disord 14:172\u2013173","journal-title":"Epileptic Disord"},{"key":"8357_CR51","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/BF01956430","volume":"153","author":"JF Magny","year":"1994","unstructured":"Magny JF, d\u2019Allest AM, Nedelcoux H, Zupan V, Dehan M (1994) Midazolam and myoclonus in neonate. Eur J Pediatr 153:389\u2013390","journal-title":"Eur J Pediatr"},{"key":"8357_CR52","first-page":"196","volume-title":"Movement Disorders","author":"CD Marsden","year":"1982","unstructured":"Marsden CD, Hallett M, Fahn S (1982) The nosology and pathophysiology of myoclonus. Movement Disorders. Butterworths, London, pp 196\u2013248"},{"key":"8357_CR53","doi-asserted-by":"crossref","first-page":"81","DOI":"10.3109\/02841869409098387","volume":"33","author":"M Martin","year":"1994","unstructured":"Martin M, Diaz-Rubio E, Casado A, Valverde JJ, Garcia Urra D, Lopez-Martin JA, Rodriguez-Lescure A (1994) Prednimustine-induced myoclonus\u2013a report of three cases. Acta Oncol 33:81\u201382","journal-title":"Acta Oncol"},{"key":"8357_CR54","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1097\/00004714-199212000-00014","volume":"12","author":"P Masand","year":"1992","unstructured":"Masand P (1992) Desipramine-induced oral-pharyngeal disturbances: stuttering and jaw myoclonus. J Clin Psychopharmacol 12:444\u2013445","journal-title":"J Clin Psychopharmacol"},{"key":"8357_CR55","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1212\/WNL.56.2.279","volume":"56","author":"K Matsunaga","year":"2001","unstructured":"Matsunaga K, Uozumi T, Qingrui L, Hashimoto T, Tsuji S (2001) Amantadine-induced cortical myoclonus. Neurology 56:279\u2013280","journal-title":"Neurology"},{"key":"8357_CR56","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0022-510X(02)00077-1","volume":"199","author":"T Meyer","year":"2002","unstructured":"Meyer T, Ludolph AC, Munch C (2002) Ifosfamide encephalopathy presenting with asterixis. J Neurol Sci 199:85\u201388","journal-title":"J Neurol Sci"},{"key":"8357_CR57","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1212\/WNL.54.10.2022","volume":"54","author":"F Micheli","year":"2000","unstructured":"Micheli F, Cersosimo MG, Scorticati MC, Velez M, Gonzalez S (2000) Myoclonus secondary to albuterol (salbutamol) instillation. Neurology 54:2022\u20132023","journal-title":"Neurology"},{"key":"8357_CR58","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1345\/aph.1K619","volume":"42","author":"D Moellentin","year":"2008","unstructured":"Moellentin D, Picone C, Leadbetter E (2008) Memantine-induced myoclonus and delirium exacerbated by trimethoprim. Ann Pharmacother 42:443\u2013447","journal-title":"Ann Pharmacother"},{"key":"8357_CR59","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1093\/jnci\/89.2.173","volume":"89","author":"C Monnerat","year":"1997","unstructured":"Monnerat C, Gander M, Leyvraz S (1997) A rare case of prednimustine-induced myoclonus. J Natl Cancer Inst 89:173\u2013174","journal-title":"J Natl Cancer Inst"},{"key":"8357_CR60","doi-asserted-by":"crossref","first-page":"337","DOI":"10.5334\/tohm.256","volume":"5","author":"AA Murgai","year":"2015","unstructured":"Murgai AA, LeDoux MS (2015) Memantine-induced Myoclonus in a Patient with Alzheimer Disease. Tremor and other hyperkinetic movements 5:337","journal-title":"Tremor and other hyperkinetic movements"},{"key":"8357_CR61","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.1002\/mds.21074","volume":"21","author":"D Nampiaparampil","year":"2006","unstructured":"Nampiaparampil D, Oruc NE (2006) Metodopramide-induced palatopharyngeal myoclonus. Mov Disord 21:2028\u20132029","journal-title":"Mov Disord"},{"key":"8357_CR62","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1097\/00002826-199506000-00010","volume":"18","author":"MY Neufeld","year":"1995","unstructured":"Neufeld MY, Vishnevska S (1995) Vigabatrin and multifocal myoclonus in adults with partial seizures. Clin Neuropharmacol 18:280\u2013283","journal-title":"Clin Neuropharmacol"},{"key":"8357_CR63","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/j.parkreldis.2015.04.026","volume":"21","author":"DA Olszewska","year":"2015","unstructured":"Olszewska DA, Chalissery AJ, Williams J, Lynch T, Smyth S (2015) Speech myoclonus due to probable pregabalin adverse drug-reaction. Parkinsonism Relat Disord 21:823\u2013824","journal-title":"Parkinsonism Relat Disord"},{"key":"8357_CR64","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1097\/WNF.0b013e31815ce4c2","volume":"31","author":"P Oulis","year":"2008","unstructured":"Oulis P, Potagas C, Masdrakis VG, Thomopoulos Y, Kouzoupis AV, Soldatos CR (2008) Reversible tremor and myoclonus associated with topiramate-fluvoxamine coadministration. Clin Neuropharmacol 31:366\u2013367","journal-title":"Clin Neuropharmacol"},{"key":"8357_CR65","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0887-8994(01)00289-2","volume":"25","author":"EA Ozer","year":"2001","unstructured":"Ozer EA, Turker M, Bakiler AR, Yaprak I, Ozturk C (2001) Involuntary movements in infantile cobalamin deficiency appearing after treatment. Pediatr Neurol 25:81\u201383","journal-title":"Pediatr Neurol"},{"key":"8357_CR66","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1097\/01.jcp.0000264995.31771.05","volume":"27","author":"SG Papageorgiou","year":"2007","unstructured":"Papageorgiou SG, Kontaxis T, Antelli A, Kalfakis N (2007) Exacerbation of myoclonus by memantine in a patient with Alzheimer disease. J Clin Psychopharmacol 27:407\u2013408","journal-title":"J Clin Psychopharmacol"},{"key":"8357_CR67","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1097\/00004714-198804000-00026","volume":"8","author":"HC Patel","year":"1988","unstructured":"Patel HC, Bruza D, Yeragani V (1988) Myoclonus with trazodone. J Clin Psychopharmacol 8:152","journal-title":"J Clin Psychopharmacol"},{"key":"8357_CR68","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1097\/00007611-199004000-00026","volume":"83","author":"JF Patterson","year":"1990","unstructured":"Patterson JF (1990) Myoclonus caused by a tricyclic antidepressant. South Med J 83:463\u2013465","journal-title":"South Med J"},{"key":"8357_CR69","doi-asserted-by":"crossref","first-page":"2643","DOI":"10.1111\/jgs.13847","volume":"63","author":"LJ Pei","year":"2015","unstructured":"Pei LJ, Tianzhi IL, Lim WS (2015) Memantine-induced myoclonus precipitated by renal impairment and drug interactions. J Am Geriatr Soc 63:2643\u20132644","journal-title":"J Am Geriatr Soc"},{"key":"8357_CR70","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1002\/mds.870110123","volume":"11","author":"RF Pfeiffer","year":"1996","unstructured":"Pfeiffer RF (1996) Amantadine-induced \u201cvocal\u201d myoclonus. Mov Disord 11:104\u2013106","journal-title":"Mov Disord"},{"key":"8357_CR71","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1002\/mds.10717","volume":"19","author":"B Post","year":"2004","unstructured":"Post B, Koelman JH, Tijssen MA (2004) Propriospinal myoclonus after treatment with ciprofloxacin. Mov Disord 19:595\u2013597","journal-title":"Mov Disord"},{"key":"8357_CR72","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.pnpbp.2009.10.006","volume":"34","author":"SK Praharaj","year":"2010","unstructured":"Praharaj SK, Venkatesh BG, Sarkhel S, Zia-ul-Haq M, Sinha VK (2010) Clozapine-induced myoclonus: a case study and brief review. Prog Neuropsychopharmacol Biol Psychiatry 34:242\u2013243","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"8357_CR73","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.eplepsyres.2011.07.020","volume":"98","author":"JB Rosen","year":"2012","unstructured":"Rosen JB, Milstein MJ, Haut SR (2012) Olanzapine-associated myoclonus. Epilepsy Res 98:247\u2013250","journal-title":"Epilepsy Res"},{"key":"8357_CR74","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1097\/01.jcp.0000219927.49799.c0","volume":"26","author":"MC Rosenhagen","year":"2006","unstructured":"Rosenhagen MC, Schmidt U, Weber F, Steiger A (2006) Combination therapy of lamotrigine and escitalopram may cause myoclonus. J Clin Psychopharmacol 26:346\u2013347","journal-title":"J Clin Psychopharmacol"},{"key":"8357_CR75","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1097\/NRL.0b013e3182704d78","volume":"18","author":"H Sarva","year":"2012","unstructured":"Sarva H, Panichpisal K (2012) Gentamicin-induced myoclonus: a case report and literature review of antibiotics-induced myoclonus. Neurologist 18:385\u2013388","journal-title":"Neurologist"},{"key":"8357_CR76","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1007\/s00415-011-5990-4","volume":"258","author":"R Savica","year":"2011","unstructured":"Savica R, Rabinstein AA, Josephs KA (2011) Ifosfamide associated myoclonus-encephalopathy syndrome. J Neurol 258:1729\u20131731","journal-title":"J Neurol"},{"key":"8357_CR77","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/j.jfma.2012.06.001","volume":"113","author":"YF Shea","year":"2014","unstructured":"Shea YF, Mok MM, Chang RS (2014) Gabapentin-induced myoclonus in an elderly with end-stage renal failure. Journal of the Formosan Medical Association =. Taiwan yi zhi 113:660\u2013661","journal-title":"Taiwan yi zhi"},{"key":"8357_CR78","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1111\/j.1399-6576.1998.tb05378.x","volume":"42","author":"P Sjogren","year":"1998","unstructured":"Sjogren P, Thunedborg LP, Christrup L, Hansen SH, Franks J (1998) Is development of hyperalgesia, allodynia and myoclonus related to morphine metabolism during long-term administration? Six case histories. Acta Anaesthesiol Scand 42:1070\u20131075","journal-title":"Acta Anaesthesiol Scand"},{"key":"8357_CR79","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1093\/ndt\/gfm713","volume":"23","author":"J Sonck","year":"2008","unstructured":"Sonck J, Laureys G, Verbeelen D (2008) The neurotoxicity and safety of treatment with cefepime in patients with renal failure. Nephrol Dial Transplant 23:966\u2013970","journal-title":"Nephrol Dial Transplant"},{"key":"8357_CR80","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1016\/j.seizure.2014.06.017","volume":"23","author":"T Spina Silva","year":"2014","unstructured":"Spina Silva T, Dal-Pra Ducci R, Zorzetto FP, Braatz VL, de Paola L, Kowacs PA (2014) Meropenem-induced myoclonus: a case report. Seizure 23:912\u2013914","journal-title":"Seizure"},{"key":"8357_CR81","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1002\/mds.21456","volume":"22","author":"P Striano","year":"2007","unstructured":"Striano P, Zara F, Coppola A, Ciampa C, Pezzella M, Striano S (2007) Epileptic myoclonus as ciprofloxacin-associated adverse effect. Mov Disord 22:1675\u20131676","journal-title":"Mov Disord"},{"key":"8357_CR82","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1345\/aph.1P301","volume":"45","author":"A Tanaka","year":"2011","unstructured":"Tanaka A, Nagamatsu T, Yamaguchi M, Nomura A, Nagura F, Maeda K, Tomino T, Watanabe T, Shimizu H, Fujita Y, Ito Y (2011) Myoclonus after dextromethorphan administration in peritoneal dialysis. Ann Pharmacother 45:e1","journal-title":"Ann Pharmacother"},{"key":"8357_CR83","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1089\/jpm.2004.7.545","volume":"7","author":"D Thwaites","year":"2004","unstructured":"Thwaites D, McCann S, Broderick P (2004) Hydromorphone neuroexcitation. J Palliat Med 7:545\u2013550","journal-title":"J Palliat Med"},{"key":"8357_CR84","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1159\/000119694","volume":"111","author":"SM Ting","year":"2008","unstructured":"Ting SM, Lee D, Maclean D, Sheerin NS (2008) Paranoid psychosis and myoclonus: flecainide toxicity in renal failure. Cardiology 111:83\u201386","journal-title":"Cardiology"},{"key":"8357_CR85","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/S0140-6736(87)92042-3","volume":"1","author":"H Tominaga","year":"1987","unstructured":"Tominaga H, Fukuzako H, Izumi K, Koja T, Fukuda T, Fujii H, Matsumoto K, Sonoda H, Imamura K (1987) Tardive myoclonus. Lancet 1:322","journal-title":"Lancet"},{"key":"8357_CR86","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1097\/JCP.0b013e318218f4d5","volume":"31","author":"L Tremolizzo","year":"2011","unstructured":"Tremolizzo L, Fermi S, Fusco ML, Susani E, Frigo M, Piolti R, Ferrarese C, Appollonio I (2011) Generalized action myoclonus associated with escitalopram in a patient with mixed dementia. J Clin Psychopharmacol 31:394\u2013395","journal-title":"J Clin Psychopharmacol"},{"key":"8357_CR87","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/0303-8467(88)90013-3","volume":"90","author":"T Uchihara","year":"1988","unstructured":"Uchihara T, Tsukagoshi H (1988) Myoclonic activity associated with cefmetazole, with a review of neurotoxicity of cephalosporins. Clin Neurol Neurosurg 90:369\u2013371","journal-title":"Clin Neurol Neurosurg"},{"key":"8357_CR88","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1212\/WNL.58.6.984","volume":"58","author":"L Vadlamudi","year":"2002","unstructured":"Vadlamudi L, Wijdicks EF (2002) Multifocal myoclonus due to verapamil overdose. Neurology 58:984","journal-title":"Neurology"},{"key":"8357_CR89","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.ajem.2003.08.004","volume":"21","author":"SG Keulen Van","year":"2003","unstructured":"Van Keulen SG, Burton JH (2003) Myoclonus associated with etomidate for ED procedural sedation and analgesia. Am J Emerg Med 21:556\u2013558","journal-title":"Am J Emerg Med"},{"key":"8357_CR90","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/BF00314716","volume":"218","author":"J Vardi","year":"1978","unstructured":"Vardi J, Glaubman H, Rabey JM, Streifler M (1978) Myoclonic attacks induced by L-dopa and bromocryptin in Parkinson patients: a sleep EEG study. J Neurol 218:35\u201342","journal-title":"J Neurol"},{"key":"8357_CR91","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1097\/WNF.0000000000000025","volume":"37","author":"SL Velasco","year":"2014","unstructured":"Velasco SL, Sierra-Hidalgo F, Rodriguez RM, Guerreo AJ, Morales JR (2014) Flecainide-induced myoclonus. Clin Neuropharmacol 37:65\u201366","journal-title":"Clin Neuropharmacol"},{"key":"8357_CR92","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1097\/00004850-200503000-00011","volume":"20","author":"L Velayudhan","year":"2005","unstructured":"Velayudhan L, Kirchner V (2005) Quetiapine-induced myoclonus. Int Clin Psychopharmacol 20:119\u2013120","journal-title":"Int Clin Psychopharmacol"},{"key":"8357_CR93","doi-asserted-by":"crossref","first-page":"E41","DOI":"10.1176\/appi.neuropsych.11080179","volume":"24","author":"A Vural","year":"2012","unstructured":"Vural A, Tezer FI (2012) Myoclonus induced by haloperidol in the intensive care unit. J Neuropsychiatry Clin Neurosci 24:E41","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"8357_CR94","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1093\/ndt\/gfh132","volume":"19","author":"L Wierre","year":"2004","unstructured":"Wierre L, Decaudin B, Barsumau J, Vairon MX, Horrent S, Odou P, Azar R (2004) Dobutamine-induced myoclonia in severe renal failure. Nephrol Dial Transplant 19:1336\u20131337","journal-title":"Nephrol Dial Transplant"},{"key":"8357_CR95","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1177\/106002809703100207","volume":"31","author":"AR Wyllie","year":"1997","unstructured":"Wyllie AR, Bayliff CD, Kovacs MJ (1997) Myoclonus due to chlorambucil in two adults with lymphoma. Ann Pharmacother 31:171\u2013174","journal-title":"Ann Pharmacother"},{"key":"8357_CR96","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1093\/ageing\/afs043","volume":"41","author":"AJ Yarnall","year":"2012","unstructured":"Yarnall AJ, Burn DJ (2012) Amantadine-induced myoclonus in a patient with progressive supranuclear palsy. Age Ageing 41:695\u2013696","journal-title":"Age Ageing"},{"key":"8357_CR97","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1016\/j.ajem.2013.02.042","volume":"31","author":"AM Yates","year":"2013","unstructured":"Yates AM, Wolfson AB, Shum L, Kehrl T (2013) A descriptive study of myoclonus associated with etomidate procedural sedation in the ED. Am J Emerg Med 31:852\u2013854","journal-title":"Am J Emerg Med"},{"key":"8357_CR98","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1007\/s00415-008-0789-7","volume":"255","author":"JH Yoon","year":"2008","unstructured":"Yoon JH, Lee PH, Yong SW, Park HY, Lim TS, Choi JY (2008) Movement disorders at a university hospital emergency room. An analysis of clinical pattern and etiology. J Neurol 255:745\u2013749","journal-title":"J Neurol"},{"key":"8357_CR99","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1684\/epd.2012.0507","volume":"14","author":"C Zanus","year":"2012","unstructured":"Zanus C, Alberini E, Costa P, Colonna F, Zennaro F, Carrozzi M (2012) Involuntary movements after correction of vitamin B12 deficiency: a video-case report. Epileptic Disord 14:174\u2013180","journal-title":"Epileptic Disord"},{"key":"8357_CR100","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1007\/s11910-007-0046-y","volume":"7","author":"TA Zesiewicz","year":"2007","unstructured":"Zesiewicz TA, Sullivan KL, Hauser RA (2007) Levodopa-induced dyskinesia in Parkinson\u2019s disease: epidemiology, etiology, and treatment. Curr Neurol Neurosci Rep 7:302\u2013310","journal-title":"Curr Neurol Neurosci Rep"},{"key":"8357_CR101","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1111\/j.0013-9580.2005.20804.x","volume":"46","author":"C Zhang","year":"2005","unstructured":"Zhang C, Glenn DG, Bell WL, O\u2019Donovan CA (2005) Gabapentin-induced myoclonus in end-stage renal disease. Epilepsia 46:156\u2013158","journal-title":"Epilepsia"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00415-016-8357-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-016-8357-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-016-8357-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,17]],"date-time":"2022-07-17T13:39:03Z","timestamp":1658065143000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00415-016-8357-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12,16]]},"references-count":101,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2017,8]]}},"alternative-id":["8357"],"URL":"https:\/\/doi.org\/10.1007\/s00415-016-8357-z","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,12,16]]}}}